Your browser doesn't support javascript.
loading
Risk factors for hospital mortality in valve replacement with mechanical prosthesis.
De Bacco, Mateus W; Sartori, Ana Paula; Sant'Anna, João Ricardo Michelin; Santos, Marisa F; Prates, Paulo Roberto; Kalil, Renato A K; Nesralla, Ivo A.
Afiliação
  • De Bacco MW; Health Sciences at IC/FUC, IC/FUC, Porto Alegre, RS, Brazil.
Rev Bras Cir Cardiovasc ; 24(3): 334-40, 2009.
Article em En, Pt | MEDLINE | ID: mdl-20011880
ABSTRACT

OBJECTIVE:

Identification of risk factors for cardiac surgery can improve surgical results. Our aim is to identify factors related to increased hospital mortality for patients who underwent mechanical cardiac prosthesis implant.

METHODS:

Prospective study with retrospective data acquirement study including 335 consecutive patients who underwent at least one implant of St. Jude Medical mechanical prosthesis between December 1994 and September 2005 at the Cardiology Institute of RS. Valve implants were 158 (47.1%) in aortic position, 146 (43.6%) in mitral and 31 (9.3%) in aortic and mitral. The following characteristics were analyzed in relation to hospital death gender, age, body mass index, NYHA functional class, ejection fraction, type of valve lesion, hypertension, diabetes mellitus, serum creatinine, preoperative arrhythmias, prior heart surgery, CABG surgery, concomitant tricuspid valve surgery and operative priority (elective, urgent or emergent). Logistical regression was used to analyze data and odds-ratio was calculated for individual factors.

RESULTS:

During the follow-up there were 13 (3.88%) deaths. In-hospital mortality risk was associated with serum creatinine (P<0.05), ejection fraction < 30% (P<0.001), mitral valve lesion (P<0.05), concomitant CABG surgery (P<0.01), prior cardiac surgery (P<0.01) and reoperation (P<0.01). Increased odd-ratio were related to previous cardiac surgery (5.36; IC95% 0.94-30.56), combined revascularization (5.28; IC95% 1.51-18.36), valvar reoperation (4.69; IC95% 0.93-23.57) and concomitant tricuspid annuloplasty (3.72; IC95% 0.75-18.30).

CONCLUSION:

The mortality rate is within the parameters found in the literature, identifying recognized factors which neutralization by changes in surgical indication and medical management may enable risk reduction.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mortalidade Hospitalar / Implante de Prótese de Valva Cardíaca Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En / Pt Revista: Rev Bras Cir Cardiovasc Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mortalidade Hospitalar / Implante de Prótese de Valva Cardíaca Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En / Pt Revista: Rev Bras Cir Cardiovasc Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Brasil